로고

INTRODUCTION

MEMBERS

RESEARCH

BOARD

RESEARCH

Pharmaceutical Economics,
Big Data Analysis & Policy Lab

Conference presentations

Total 160건 6 페이지

2022
85

"Differences in the health-related quality of life between diabetic patients with and those without comorbidities in South Korea" Kim M and Suh HS , The 2022 International Society for Pharmacoeconomics and Outcomes Research Europe Vienna, Austria. November 2022.
84

"A qualitative study of measuring health related quality of life in Migraine patients: Comparing EQ-5D and MSQ v2.1 questionnaires" Yoon H and Suh HS , The 2022 International Society for Pharmacoeconomics and Outcomes Research Europe Vienna, Austria. November 2022.
83

"Economic impact before and after expensive drug reimbursement with diabetic macular edema in South Korea" Choi K, Park SJ, Yoon H and Suh HS , The 2022 International Society for Pharmacoeconomics and Outcomes Research Europe Vienna, Austria. November 2022.
82

"Quality of Life and Productivity losses of dysmenorrhea patients in Korea" Yoon H and Suh HS , The 2022 International Society for Pharmacoeconomics and Outcomes Research Europe Vienna, Austria. November 2022.
81

"Exploring the treatment patterns of bipolar disorder using the Observational Medical Outcomes Partnership Common Data Model" Kim S and Suh HS , The 2022 International Society for Pharmacoeconomics and Outcomes Research Europe Vienna, Austria. November 2022.
80

"Difference of statin prescription ratio in Diabetes Mellitus patient and non-Diabetes mellitus patient" Choi JH, Yoon H and Suh HS , The 2022 Fall International Convention of The Pharmaceutical Society of Korea Jeju, Korea. October 2022.
79

"Analysis of treatment pathway for hypertension in pregnancy using CDM(Common data model)" Kim SY, Lee KE and Suh HS , The 2022 Fall International Convention of The Pharmaceutical Society of Korea Jeju, Korea. October 2022.
78

"Treatment pathways of antiepileptics according to gender and age using common data model" Kim MK, Lee EJ and Suh HS , The 2022 Fall International Convention of The Pharmaceutical Society of Korea Jeju, Korea. October 2022.
77

"Medication Treatment Pathways in Chronic Urticaria patients from electronic health record using OMOP-CDM (common data model)" Oh J, Kim Y and Suh HS , The 2022 Fall International Convention of The Pharmaceutical Society of Korea Jeju, Korea. October 2022.
76

"The effect of expanding reimbursement criteria for G-csf injections In cancer patients; an interrupted time series" Kim D, Choi K, Kim Y and Suh HS , The 2022 Fall International Convention of The Pharmaceutical Society of Korea Jeju, Korea. October 2022.
75

"HERMES: A Health Resources Econometric Analysis Tool" Choi K, Park SJ, Han S, Kim S and Suh HS , The 2022 Observational Health Data Sciences and Informatics Washington DC, USA. October 2022.
74

"Productivity Loss and Indirect Costs Associated with Migraine and Probable Migraine in Korea" Kim Y, Han S and Suh HS , The 2022 International Society for Pharmacoeconomics and Outcomes Research Washington, DC, USA. May 2022.
73

"Investigating Undergraduate Students’ Perception on COVID-19 Pandemic and Social Distance and Its Influencing Factors By Association Analysis and Sentimental Analysis" Lee K, Han S, Osipenko L and Suh HS , The 2022 International Society for Pharmacoeconomics and Outcomes Research Washington, DC, USA. May 2022.
72

"Economic Burden of Disease in Patients with Exudative Age-Related Macular Degeneration Using Common Data Model in South Korea" Choi K, Park SJ, Han S and Suh HS , The 2022 International Society for Pharmacoeconomics and Outcomes Research Washington, DC, USA. May 2022.
71

"Real-World Effectiveness of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Population-Based Study in South Korea" Kim S and Suh HS , The 2022 International Society for Pharmacoeconomics and Outcomes Research Washington, DC, USA. May 2022.

검색